Crossmark

Evaluation of the gut microbiome and sex hormones in postmenopausal women with newly diagnosed hormone receptor-positive breast cancer versus healthy women: a prospective case-control study

Crossref DOI link: https://doi.org/10.1007/s00432-025-06338-z

Published Online: 2025-10-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kwa, Maryann https://orcid.org/0000-0003-4708-1381
Hussey, Grant

Novik, Yelena

Franke, Adrian A.

Volkova, Angelina

Flores, Karina

Blaser, Martin J.

Speyer, James

Oratz, Ruth

Meyers, Marleen

Jhaveri, Komal

Fadel, Ezeddin

Heguy, Adriana

Schluter, Jonas

Ruggles, Kelly V.

Adams, Sylvia
Funding

Funding for this research was provided by:

National Institutes of Health (P30CA71789)

National Institutes of Health (5P30CA16087-40)

Dyson Foundation
License Information

Text and Data Mining valid from 2025-10-04

Version of Record valid from 2025-10-04
More Information

Article History

Received: 21 April 2025

Accepted: 18 September 2025

First Online: 4 October 2025

Declarations

:

: Jonas Schluter is co-founder and holds equity in Postbiotics Plus Research. He serves on an Advisory board and holds equity of Jona Health. He has filed intellectual property applications related to the microbiome (reference numbers #63/299,607). The other authors have no relevant financial or non-financial interests to disclose.

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the NYU Grossman School of Medicine Institutional Review Board.

: Informed consent was obtained from all individual participants included in the study.

Document is current

Any future updates will be listed below